Patents Assigned to Tularik, Incorporated
  • Methods of assaying for compounds that inhibit premature translation termination and nonsense-mediated RNA decay
    Patent number: 6458538
    Abstract: The present application provides methods of assaying for compounds that inhibit premature translation termination and nonsense mediated RNA decay in cells.
    Type: Grant
    Filed: December 14, 1999
    Date of Patent: October 1, 2002
    Assignees: PTC Therapeutics, Inc., Tularik Incorporated
    Inventors: Holger Beckmann, Marc Learned, Stuart Peltz, Kevin Czaplinski
  • High throughput in vitro screening assays for transcription modulators
    Patent number: 6183956
    Abstract: High-throughput in vitro assays are provided for identifying modulators of transcription activity and RNA expression. New assays, related compositions, apparatus and integrated systems are provided.
    Type: Grant
    Filed: March 31, 1998
    Date of Patent: February 6, 2001
    Assignee: Tularik, Incorporated
    Inventors: Mohanram Sivaraja, Berta Strulovici, Osvaldo A. Flores